Sanofi and Bristol gain EU support for wider approval of Plavix

11/21/2010 | Reuters

Bristol-Myers Squibb and Sanofi-Aventis have obtained the European Medicines Agency's endorsement to use anti-clotting drug Plavix for the prevention of thromboembolic and atherothrombotic events in certain adults with atrial fibrillation.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY